Annual SGA
$214.30 K
-$3.32 M-93.94%
December 1, 2023
Summary
- As of February 8, 2025, CYTO annual SGA is $214.30 thousand, with the most recent change of -$3.32 million (-93.94%) on December 1, 2023.
- During the last 3 years, CYTO annual SGA has fallen by -$2.76 million (-92.79%).
- CYTO annual SGA is now -95.97% below its all-time high of $5.31 million, reached on December 31, 2016.
Performance
CYTO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
N/A
June 1, 2024
Summary
- CYTO quarterly SGA is not available.
Performance
CYTO Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM SGA
-$23.42 M
+$23.33 M+49.91%
June 1, 2024
Summary
- As of February 8, 2025, CYTO TTM SGA is -$23.42 million, with the most recent change of +$23.33 million (+49.91%) on June 1, 2024.
- CYTO TTM SGA is now -567.02% below its all-time high of -$3.51 million.
Performance
CYTO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CYTO Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -93.9% | - | - |
| 3 y3 years | -92.8% | - | - |
| 5 y5 years | -94.8% | - | - |
CYTO Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -94.6% | at low | at high | +94.3% | ||
| 5 y | 5-year | -94.7% | at low | at high | +94.3% | ||
| alltime | all time | -96.0% | at low | -567.0% | +96.0% |
Altamira Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $214.30 K(-93.9%) | - | - |
| Dec 2022 | $3.54 M(-11.1%) | - | - |
| Dec 2021 | $3.98 M(+34.0%) | - | - |
| Dec 2020 | $2.97 M(-26.4%) | - | - |
| Dec 2019 | $4.03 M(-1.9%) | - | - |
| Dec 2018 | $4.11 M(-20.9%) | $413.70 K(-65.3%) | $4.13 M(-14.2%) |
| Sep 2018 | - | $1.19 M(+8.3%) | $4.82 M(-3.6%) |
| Jun 2018 | - | $1.10 M(-22.8%) | $5.00 M(-3.7%) |
| Mar 2018 | - | $1.43 M(+30.2%) | $5.19 M(+0.0%) |
| Dec 2017 | $5.20 M(-2.2%) | $1.10 M(-20.1%) | $5.18 M(+1.4%) |
| Sep 2017 | - | $1.37 M(+6.0%) | $5.11 M(+2.6%) |
| Jun 2017 | - | $1.29 M(-9.2%) | $4.98 M(-8.6%) |
| Mar 2017 | - | $1.42 M(+39.2%) | $5.45 M(+3.0%) |
| Dec 2016 | $5.31 M | $1.02 M(-17.4%) | $5.29 M(+0.5%) |
| Sep 2016 | - | $1.24 M(-29.6%) | $5.26 M(-2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2016 | - | $1.76 M(+39.1%) | $5.39 M(+15.0%) |
| Mar 2016 | - | $1.27 M(+27.0%) | $4.69 M(+7.0%) |
| Dec 2015 | $4.33 M(+19.1%) | $997.10 K(-27.0%) | $4.38 M(+33.4%) |
| Sep 2015 | - | $1.37 M(+29.1%) | $3.28 M(+10.7%) |
| Jun 2015 | - | $1.06 M(+10.1%) | $2.97 M(+3.8%) |
| Mar 2015 | - | $961.00 K(-1053.4%) | $2.86 M(-25.3%) |
| Dec 2014 | $3.63 M(+145.6%) | -$100.80 K(-109.6%) | $3.82 M(-10.8%) |
| Sep 2014 | - | $1.05 M(+10.6%) | $4.29 M(+19.8%) |
| Jun 2014 | - | $948.30 K(-50.8%) | $3.58 M(+14.7%) |
| Mar 2014 | - | $1.93 M(+429.8%) | $3.12 M(+111.0%) |
| Dec 2013 | $1.48 M(+129.1%) | $363.70 K(+6.7%) | $1.48 M(+32.6%) |
| Sep 2013 | - | $341.00 K(-30.4%) | $1.12 M(+44.0%) |
| Jun 2013 | - | $490.10 K(+72.3%) | $774.50 K(+172.3%) |
| Mar 2013 | - | $284.40 K | $284.40 K |
| Dec 2012 | $645.80 K | - | - |
FAQ
- What is Altamira Therapeutics annual SGA?
- What is the all time high annual SGA for Altamira Therapeutics?
- What is Altamira Therapeutics annual SGA year-on-year change?
- What is the all time high quarterly SGA for Altamira Therapeutics?
- What is Altamira Therapeutics TTM SGA?
- What is the all time high TTM SGA for Altamira Therapeutics?
What is Altamira Therapeutics annual SGA?
The current annual SGA of CYTO is $214.30 K
What is the all time high annual SGA for Altamira Therapeutics?
Altamira Therapeutics all-time high annual SGA is $5.31 M
What is Altamira Therapeutics annual SGA year-on-year change?
Over the past year, CYTO annual SGA has changed by -$3.32 M (-93.94%)
What is the all time high quarterly SGA for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly SGA is $1.93 M
What is Altamira Therapeutics TTM SGA?
The current TTM SGA of CYTO is -$23.42 M
What is the all time high TTM SGA for Altamira Therapeutics?
Altamira Therapeutics all-time high TTM SGA is -$3.51 M